ESC 365 - Reduction of arteriosclerotic cardiovascular disease risk by glucose-lowering medications in diabetes

Open Access

Reduction of arteriosclerotic cardiovascular disease risk by glucose-lowering medications in diabetes

Session: 2023 ESC Guidelines for the Management of Cardiovascular Disease in Patients with Diabetes

Topic: Diabetes and the Heart

Speaker: Professor D. McGuire (Dallas, US)

Event: ESC Congress 2023

Congress Presentation

About the speaker

Professor Darren Keith McGuire

University of Texas Southwestern Medical Center, Dallas (United States of America)

20 presentations

0 follower

5 more presentations in this session

Introduction

Speaker: Professor N. Marx (Aachen, DE)

SCORE2-diabetes: cardiovascular risk assessment in patients with type 2 diabetes

Speaker: Professor E. Di Angelantonio (Cambridge, GB)

Antithrombotic therapy in diabetes

Speaker: Professor B. Rocca (Rome, IT)

Heart failure and diabetes

Speaker: Assistant Professor K. Schuett (Aachen, DE)

Chronic kidney disease and diabetes

Speaker: Professor W. Herrington (Oxford, GB) Professor D. Mueller-Wieland (Aachen, DE)

Access the full session

2023 ESC Guidelines for the Management of Cardiovascular Disease in Patients with Diabetes

Speakers: Professor D. McGuire, Professor N. Marx, Professor E. Di Angelantonio, Professor B. Rocca, Assistant Professor K. Schuett...

About the event

ESC Congress 2023

25 August - 28 August 2023

Sessions Presentations

Congress

ESC 365 is supported by